CDMO News Catalent x Novo: GLP-1 and Antitrust Concerns as Industry Reacts to the $16.5B Acquisition 9 February 2024
Category Guide GLP-1 Drug Market: the rapid growth of the diabetes and obesity drugs market 12 January 2024
